27.01
前日終値:
$27.58
開ける:
$27.58
24時間の取引高:
266.42K
Relative Volume:
0.61
時価総額:
$1.24B
収益:
$722.68M
当期純損益:
$134.71M
株価収益率:
10.12
EPS:
2.67
ネットキャッシュフロー:
$109.94M
1週間 パフォーマンス:
-1.28%
1か月 パフォーマンス:
+6.93%
6か月 パフォーマンス:
+4.45%
1年 パフォーマンス:
-39.03%
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
名前
Amphastar Pharmaceuticals Inc
セクター
電話
909-980-9484
住所
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
AMPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
AMPH
Amphastar Pharmaceuticals Inc
|
27.01 | 1.27B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
120.41 | 54.02B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.28 | 45.21B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.53 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.41 | 31.93B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
485.21 | 20.71B | 3.08B | 1.24B | 1.07B | 25.61 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-12 | アップグレード | Needham | Hold → Buy |
| 2025-05-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-02-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | 開始されました | Wells Fargo | Equal Weight |
| 2024-03-05 | 開始されました | JP Morgan | Overweight |
| 2023-11-17 | 開始されました | BofA Securities | Neutral |
| 2023-07-25 | 再開されました | Jefferies | Buy |
| 2022-10-21 | 再開されました | Jefferies | Buy |
| 2022-07-29 | 開始されました | CapitalOne | Overweight |
| 2022-01-07 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | 開始されました | Northland Capital | Outperform |
| 2019-03-13 | ダウングレード | Needham | Buy → Hold |
| 2019-03-13 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | 繰り返されました | Needham | Buy |
| 2018-03-13 | 繰り返されました | Needham | Buy |
| 2017-12-01 | 繰り返されました | Needham | Buy |
| 2017-11-09 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | 繰り返されました | Needham | Buy |
| 2017-03-14 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | 繰り返されました | Needham | Buy |
| 2016-05-10 | 繰り返されました | Needham | Buy |
| 2016-02-19 | 開始されました | Wells Fargo | Outperform |
| 2015-06-19 | 繰り返されました | Needham | Buy |
| 2015-06-03 | 開始されました | Raymond James | Strong Buy |
| 2014-07-21 | 開始されました | Needham | Buy |
すべてを表示
Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース
Will Amphastar Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - Newser
Will Amphastar Pharmaceuticals Inc. (29A) stock recover faster than industry2025 Retail Activity & Daily Profit Focused Stock Screening - Newser
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of "Hold" from Analysts - MarketBeat
How Amphastar Pharmaceuticals Inc. (29A) stock expands through international marketsRecession Risk & Long-Term Safe Investment Plans - Newser
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why - The Globe and Mail
Will Amphastar Pharmaceuticals Inc. (29A) stock benefit from infrastructure bill2025 Price Targets & Capital Protection Trade Alerts - Newser
Trend Recap: How strong is Amphastar Pharmaceuticals Inc stock revenue growth - BỘ NỘI VỤ
Will Amphastar Pharmaceuticals Inc. (29A) stock deliver stable dividendsWeekly Trade Recap & Precise Buy Zone Identification - Newser
Is Amphastar Pharmaceuticals Inc. stock a good choice for value investorsTrade Analysis Report & Long-Term Safe Return Strategies - Newser
Is Amphastar Pharmaceuticals Inc. (29A) stock at risk of policy regulationQuarterly Performance Summary & High Yield Equity Trading Tips - Newser
Can Amphastar Pharmaceuticals Inc. (29A) stock double in coming years2025 Price Targets & Real-Time Price Movement Reports - Newser
Creative Planning Acquires 22,493 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Geode Capital Management LLC Buys 18,161 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted? - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) Is Up 6.5% After Earnings Beat and Pipeline Expansion—What's Changed? - Sahm
A Look at Amphastar Pharmaceuticals (AMPH) Valuation Following Strong Quarterly Results and Pipeline Progress - Yahoo Finance
VP Zhou Files To Sell 20,000 Of Amphastar Pharmaceuticals Inc [AMPH] - TradingView
SG Americas Securities LLC Acquires Shares of 24,448 Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
A Look at Amphastar Pharmaceuticals’s Valuation After Upbeat Earnings and Strategic Pipeline Moves (AMPH) - Sahm
Will Amphastar’s (AMPH) Q3 Earnings Beat Amid Margin Pressure Shift Its Competitive Narrative? - Sahm
Magnetar Financial LLC Invests $306,000 in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar (AMPH) Q3 2025 Earnings Call Transcript - The Globe and Mail
Richard Prins Sells 4,179 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat
Understanding Momentum Shifts in (AMPH) - news.stocktradersdaily.com
Amphastar pharma director Prins sells $113,253 in shares By Investing.com - Investing.com Canada
[Form 4] Amphastar Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Amphastar Pharmaceuticals Director Sells Shares - TradingView
Dir Prins Sells 4,179 ($113.3K) Of Amphastar Pharmaceuticals Inc [AMPH] - TradingView
Amphastar Pharmaceuticals- Growth has been impressive, Can it continue? - Yahoo Finance
Amphastar Pharmaceuticals- Growth has been impressive, Can it c - GuruFocus
Dynamic Technology Lab Private Ltd Takes Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference - standard-journal.com
Amphastar Pharmaceuticals, Inc. (AMPH) Stock forecasts - Yahoo Finance UK
Amphastar Shares Surge Following Impressive Quarterly Earnings Report - Ad-hoc-news.de
Amphastar stock hits 52-week low at $31.54 amid market challenges - MSN
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - The Globe and Mail
How Amphastar Pharmaceuticals Inc. stock reacts to oil pricesWeekly Investment Summary & Real-Time Market Sentiment Reports - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock is listed among top recommendationsQuarterly Trade Report & Safe Entry Momentum Tips - newser.com
Amphastar Expects Mysterious Inhaler Candidate To Be The ‘Most Meaningful’ Revenue Driver In 2026 - Citeline News & Insights
Will Amphastar Pharmaceuticals Inc. (29A) stock boost dividends furtherJuly 2025 Rallies & Safe Swing Trade Setup Alerts - newser.com
Amphastar Pharmaceuticals : Q3 Financial Results (AMP 2025 Q3 Earnings Release FINAL) - MarketScreener
Will Amphastar Pharmaceuticals Inc. stock recover faster than marketWeekly Trend Recap & Stock Portfolio Risk Control - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock could be next leaderJuly 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com
How risky is Amphastar Pharmaceuticals Inc. (29A) stock compared to peersWeekly Investment Summary & Technical Pattern Based Signals - newser.com
Amphastar Pharmaceuticals Inc (AMPH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):